Should You Buy This Big Pharma Stock?

Two characteristics are indicative of a pharma stock that can meaningfully increase a shareholder's wealth over the long term. First, a prospective stock should have a diversified portfolio of cutting-edge therapies on the market. Second, the stock should have a good amount of potential blockbuster drugs in its pipeline and undergoing clinical trials. These two traits allow for a stock's revenue and earnings capacity to keep growing consistently.

AstraZeneca (NASDAQ: AZN) is one pharma stock that appears to meet these requirements. But is it a buy? Let's dive into the stock's fundamentals and valuation to try to answer that question.

Image source: Getty Images.

Continue reading

Source Fool.com